N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels

Lucky Togihon Harjantho; Suryanti Dwi Pratiwi; Susanthy Djajalaksana; Aditya Sri Listyoko; Harun Al Rasyid

doi:10.36948/ijfmr.2024.v06i01.5554

N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels

Author(s)	Lucky Togihon Harjantho, Suryanti Dwi Pratiwi, Susanthy Djajalaksana, Aditya Sri Listyoko, Harun Al Rasyid
Country	Indonesia
Abstract	Introduction: Many unique pathologies, such as hyperinflammation and hypercoagulopathy, have been associated with Covid-19, resulting in critical illness and poor outcomes. N-Acetylcysteine (NAC), a precursor of the antioxidant glutathione, has a number of biological effects, including increasing antioxidant capacity, inhibiting viral replication, and suppressing the release of proinflammatory cytokines, such as IL-1????, which further reduces coagulopathy as measured by D-dimer and PADUA scores. The aim of this research is to analyze the effect of NAC as an adjunctive therapy on the level of IL-1????, D-dimer and PADUA scores among Covid-19 patients. Method: A quasi-experimental, non-equivalent group, single-center study included 91 hospitalized confirmed Covid-19 patients by RT-PCR, 75 patients received standard of care plus 5000 mg/72 hours of NAC and 16 patients received standard of care without NAC. On the first and eighth days of treatment, IL-1????, D-dimer levels, and PADUA scores were measured by ELISA and quantitative-assay methods. Data analysis used were Mann-Whitney test, Wilcoxon test, and Spearman-rho correlation test. Result: After the eighth day of therapy, the NAC group had a statistically significantly reduction in IL-1????(pg/mL) (1,48[-4,23-6,68] vs -0,43[-3,40-2,0], p=0.03) and D-dimer(µg/mL) (0,75[-5,98-6,45] vs -0,03[-8,07-1,00], p<0,001) levels than the control group, but not in PADUA scores (1,05[0-3] vs 0,94[0-1], p=0,458). In a subanalysis of NAC's group, IL-1???? was found to be quite strongly correlated with D-dimer (r=0,508, p<0,001). Conclusion: Our findings show that supplementary NAC reduces hyperinflammation and hypercoagulopathy in Covid-19 patients by suppressing IL-1???? and lowering D-dimer, and thus could be used as a supplement to Covid-19 therapy.
Keywords	COVID-19, N-acetylcysteine, IL-1????, coagulopathy, D-dimer
Field	Medical / Pharmacy
Published In	Volume 6, Issue 1, January-February 2024
Published On	2024-02-10
Cite This	N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels - Lucky Togihon Harjantho, Suryanti Dwi Pratiwi, Susanthy Djajalaksana, Aditya Sri Listyoko, Harun Al Rasyid - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.5554
DOI	https://doi.org/10.36948/ijfmr.2024.v06i01.5554
Short DOI	https://doi.org/gthqr9

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6 Cover Page Vol 6 Isu 5 Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

N-Acetylcysteine as A Potential Adjunctive Theraphy in Covid-19 Patients Associated Coagulopathy by Lowering Il-1????, D-dimer and Padua Scores Levels

Share this